9C0P
M. tuberculosis PKS13 acyltransferase (AT) domain in complex with SuFEx inhibitor CEC215
This is a non-PDB format compatible entry.
Summary for 9C0P
Entry DOI | 10.2210/pdb9c0p/pdb |
Related PRD ID | PRD_900003 |
Descriptor | Polyketide synthase Pks13, beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose, PENTAETHYLENE GLYCOL, ... (6 entities in total) |
Functional Keywords | polyketide synthase, acyltransferase, tuberculosis, inhibitor, structural genomics, tb structural genomics consortium, tbsgc, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Mycobacterium tuberculosis |
Total number of polymer chains | 2 |
Total formula weight | 116701.37 |
Authors | Krieger, I.K.,Tang, S.,Sacchettini, J.C.,TB Structural Genomics Consortium (TBSGC) (deposition date: 2024-05-27, release date: 2025-05-07) |
Primary citation | Krieger, I.K.,Sacchettini, J.C.,McNamara, C.W. A SuFEx-based TB clinical candidate irreversibly inhibits Pks13 To Be Published, |
Experimental method | X-RAY DIFFRACTION (1.87 Å) |
Structure validation
Download full validation report
